PAVmed PAVM is gearing up to announce its quarterly earnings on Wednesday, 2024-11-13. Here's a quick overview of what investors should know before the release.
Analysts are estimating that PAVmed will report an earnings per share (EPS) of $1.97.
Investors in PAVmed are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Earnings History Snapshot
During the last quarter, the company reported an EPS beat by $0.61, leading to a 7.5% drop in the share price on the subsequent day.
Here's a look at PAVmed's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -1.45 | -1.67 | -1.89 | -2.1 |
| EPS Actual | -0.84 | -0.99 | -1.33 | -3.3 |
| Price Change % | -8.0% | 16.0% | 33.0% | 0.0% |
Stock Performance
Shares of PAVmed were trading at $1.12 as of November 11. Over the last 52-week period, shares are down 57.76%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.
To track all earnings releases for PAVmed visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
